Charles Schwab’s stock-picking chief told us why a COVID-19 vaccine would trigger a mass exit from tech stocks — and pinpoints 3 companies that would benefit instead (RTX, PH, VFC)
Published
· Large-cap tech stocks have benefited from a demand surge amid the pandemic.
· Some on Wall Street, including Charles Schwab's Bill McMahon, believe a vaccine will be the catalyst that drives investors away from tech.
· McMahon listed two sectors and three stocks that he believes would benefit most from demand shifts...